News

Scary or sweet? Read about the value of nonverbal communication and have some spooky fun.

Adial Pharmaceuticals announced the reactivated US Investigational application for their Alcohol Use Disorder therapeutic agent, AD04.

While COVID-19 has certainly caused a physical health pandemic, it is taking a heavy toll on mental health too, to the point that strategic action is clearly needed.

A significant proportion of incarcerated individuals struggle with with addiction. So what is being done about it?

Oxcarbazepine might be considered for patients who you want to treat with carbamazepine for mania (as monotherapy or adjunct) but for whom it would be unsafe or who have been unable to tolerate it.

When switching to this long-acting injectable antipsychotic, how long should an oral pre-switch antipsychotic be continued? Find out in this quiz.

Racism is a problem that exists in our space. A new advocacy moment is here, and it needs to be seized.

In this interview with Dr Aftab, Dr de Haan discusses her enactive approach to psychiatry which applies insights from enactivism to help conceptualize and navigate the immense complexity of factors that contribute to psychiatric disorders, and articulates the enactive view of psychiatric disorders as disorders of sense-making.

In this interview with Dr Aftab, Dr Nielsen discusses his approach to psychiatry which sees mental disorders as dysfunctions in the behavioral and experiential processes representing “sticky tendencies” in the human brain-body-environment system.

Akili announces new data on treatment EndeavorRx that reports real-world improvement for children with ADHD.

In the early days of the pandemic, there was debate about whether clinical services for patients with psychiatric illness were “essential.” The evolution of psychiatric consultation-liaison services to medically hospitalized patients was no less complex.

He was happy in a Gettysburg field, before he turned 13. That was the year his father’s body launched its own Civil War.

Dr Pies offers an analysis of psychiatry’s place on the spectrum of science using “causality” and “meaning” as lenses.

Eradicating structural racism takes actions both big and small. Read more to learn about one doctor’s experience and what you can do in your own practice.

Given the significant variation in medical cannabis laws amongst states and the continually shifting legal landscape regarding its use, medical cannabis presents a unique challenge for medical professionals who consider recommending it to their patients

Drug-drug interactions are complicating COVID-19 treatment. Read what you need to know to keep yourself and your patients safe before and during COVID infection.

A recent study presents new findings on the connection between psychiatric disorders and Lyme.

New and improved treatment options are surfacing, thanks to an improved understanding of psychoneuroendocrinology.

While there are risks for prescribing benzodiazepines and opioids concurrently, experts agree there are times when it may be an appropriate treatment decision.

One doctor shares her experience of treating black patients, and calls on you to help make reparations for the harm psychiatry has caused.

Carlos M. Grilo, PhD, explained symptoms, causes, and treatment for binge-eating disorder in his talk at The Annual Psychiatric Times® World CME Conference™.

Can algorithms improve how you practice? Dr Osser explained more in his speech at the Annual Psychiatric Times® World CME Conference™.

We have learned that in order to provide much-needed social support during difficult times, organizations should prepare to take certain steps.

Often misdiagnosed as other psychiatric disorders, FTD is the third most common type of dementia and the second most common among patients 65 years or younger. How to spot the signs.

New research is being conducted on how psychedelic substances may change the future of mental health care. Dr Carlin explained more in her speech at the Annual Psychiatric Times® World CME Conference™.

Cannabis and cannabis-derived products are widely debated. Dr Gorelick covered the issues surrounding this substance. Read more for highlights.

Clinicians have a limited repertoire when it comes to a dual approach to migraine and psychiatric treatment. Read more about Dr Moawad's presentation at the Annual Psychiatric Times® World CME Conference™.

Benzodiazepines, a drug used to treat anxiety and other conditions, has been mandated to alter their safety warnings. Read about the latest.

“The best indicator of the future is looking at the past,” Sidney Zisook, MD, told attendees of the Annual Psychiatric Times® World CME Conference™. Dr Zisook spoke to the future of psychiatry in the Educator of the Year Lecture.